Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells

Journal of Clinical Investigation

Volumn 97, Issue 3, 1996, Pages 736-745

  Shindo, Hideo ^a,b   Thomas, Thommey P ^a   Larkin, Dennis D ^a   Karihaloo, Anil K ^a   Inada, Hidetoshi ^b   Onaya, Toshimasa ^b   Stevens, Martin J ^a   Greene, Douglas A ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

diabetes; diabetic neuropathy; myo inositol; nitric oxide; protein kinase C

Indexed keywords

CYCLIC GMP; GLUCOSE; INOSITOL; NITRIC OXIDE; PROTEIN KINASE;

ARTICLE; CANCER CELL CULTURE; DIABETIC NEUROPATHY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; NERVE CONDUCTION; NEUROBLASTOMA CELL; OXIDATION REDUCTION REACTION; PATHOGENESIS; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL;

EID: 0030045207     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118472     Document Type: Article

References (95)

1. Schmidt, H.H., and U Walter. 1994. NO at work Cell 78:919-925.
2. Sessa, W.C. 1994. The nitric oxide synthase family of proteins. J. Vasc. Res. 31:131-143.
3. Zhang, J , V.L. Dawson, T.M. Dawson, and S.H. Snyder. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science (Wash. DC). 263:687-689.
4. Keaney, J F., Jr., D.I. Simon, J.S. Stamler, O. Jaraki, J. Scharfstein, J A. Vita, and J Loscalzo. 1993. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin Invest. 91:1582-1589.
5. Bult, H., G.E. Boeckxstaens, P.A. Pelckmans, F.H. Jordaens, Y M. Van Maercke, and A.G Herman. 1990. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature (Lond.) 345:346-347.
6. Low, P.A., and R.R. Tuck. 1984. Effects of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J. Physiol. 347: 513-524.
7. Oyama, Y., H Kawasaki, Y. Hatton, and M. Kanno. 1986. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol 132:75-78
8. Abiru, T., Y. Watanabe, K. Kamata, N. Miyata, and Y. Kasuya. 1990 Decrease in endothelium-dependent relaxation and levels of cyclic nucleotides in aorta from rabbits with alloxan-induced diabetes. Res. Commun Chem. Pathol. Pharmacol. 68.13-25.
9. Tesfamariam, B , M.L. Brown, and R.A. Cohen. 1991. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87:1643-1648.
10. Chang, K.S., and W.C. Stevens. 1992. Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br. J. Pharmacol. 107.983-990.
11. Wang, Y X., D.P. Brooks, and R.M. Edwards. 1993 Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats. Am J Physiol. 264:R952-R956.
12. Craven, P.A , R.K Studer, and F.R. DeRubertis 1994. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response. J. Clin Invest. 93:311-320.
13. Stevens, M.J., J. Dananberg, E.L. Feldman, S.A Lattimer, M. Kamijo, T.P. Thomas, H. Shindo, A A Sima, and D.A. Greene. 1994. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat J. Clin. Invest. 94:853-859.
14. Tilton, R.G., K. Chang, K.S Hasan, S.R. Smith, J.M. Petrash, T.P. Misko, W.M. Moore, M.G. Curne, J.A Corbett, M.L. McDaniel, et al 1993. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes. 42: 221-232.
15. Greene, D.A., S Lattimer-Greene, and A.A. Sima. 1989. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Crit. Rev. Neurobiol. 5:143-219.
16. Kim, J , E.H Rushovich, T.P. Thomas, T. Ueda, B.W. Agranoff, and D A. Greene. 1991. Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes 40:1545-1554.
17. Zhu, X., and J. Eichberg. 1990. A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 87:9818-9822.
18. Zhu, X., and J. Eichberg. 1990. 1,2-diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J. Neurochem. 55:1087-1090.
19. Thomas, T.P., E.L Feldman, J. Nakamura, K Kato, M. Lien, M.J. Stevens, and D A. Greene. 1993. Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cell culture. Proc Natl. Acad Sci. USA. 90:9712-9716.
20. Borghini, I., K. Geering, A. Gjinovci, C.B. Wollheim, and W.F. Pralong. 1994. In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and diabetic rats, effects of protein kinase modulators. Proc. Natl. Acad. Sci. USA. 91:6211-6215.
21. Yorek, M A., J.A. Dunlap, and B.H. Ginsberg. 1987. myo-Inositol metabolism in 41A3 neuroblastoma cells: effects of high glucose and sorbitol levels. J. Neurochem. 48:53-61.
22. Yorek, M.A., J.A. Dunlap, and E.M. Leeney. 1989. Effect of galactose and glucose levels and sorbinil treatment on myo-inositol metabolism and Na+-K+ pump activity in cultured neuroblastoma cells. Diabetes. 38:996-1004.
23. McKinney, M., C. Bolden, C. Smith, A. Johnson, and E. Richelson. 1990. Selective blockade of receptor-mediated cyclic GMP formation in N1E-115 neuroblastoma cells by an inhibitor of nitric oxide synthesis. Eur. J. Pharmacol. 178:139-140
24. Chaki, S., and T. Inagami 1993. New signalling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol Pharmacol. 43:603-608.
25. Pahlman, S., G. Meyerson, E. Lindgren, M. Schalting, and I. Johansson. 1991. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. USA. 88:9994-9998.
26. Nakamura, J., M A. Del Monte, D Shewach, S.A Lattimer, and D.A Greene. 1992. Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells. Am. J. Physiol. 262:E417-E426.
27. Yasuda, I , A. Kishimoto, S. Tanaka, M. Tominaga, A. Sakurai, and Y. Nishizuki. 1990. A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys Res. Commun 166:1220-1227.
28. Chakravaarthy, B.R., J. Isaacs, P. Morley, J.P. Durkin, and J.F. Whitfield. 1995. Stimulation of protein kinase C during Ca(2+)-induced keratinocyte differentiation. Selective blockade of MARCKS phosphorylation by calmodulin. J. Biol Chem. 270:1362-1368.
29. Smith, P.K , R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C Klenk. 1985. Measurement of protein using bicinchoninic acid [published erratum appears in Anal Biochem. 1987. 163:279]. Anal. Biochem. 150:76-85.
30. 15N] nitrate in biological fluids. Anal Biochem. 126:131-138.
31. Fujisawa, H., T. Ogura, Y. Kurashima, T. Yokoyama, J. Yamashita, and H. Esumi. 1994. Expression of two types of nitric oxide synthase mRNA in human neuroblastoma cell lines. J. Neurochem. 63:140-145
32. Janssens, S.P , A. Shimouchi, T Quertermous, D.B. Bloch, and K.D. Bloch. 1992. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase [published erratum appears in J. Biol. Chem. 1992.267:22694]. J. Biol. Chem. 267:14519-14522.
33. Bredt, D.S., P.M. Hwang, C.E. Glatt, C. Lowenstein, R.R. Reed, and S.H Snyder. 1991. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature (Lond ). 351.714-718.
34. Geller, D.A., C.J Lowenstein, R.A. Shapiro, A.K. Nussler, M. Di Silvio, S.C Wang, D.K. Nakayama, R.L. Simmons, S.H. Snyder, and T.R. Billiar. 1993 Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA. 90:3491-3495.
35. Stevens, M J , D.N Henry, T.P Thomas, P.D. Killen, and D.A. Greene. 1993. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells. Am. J. Physiol 265:E428-E438.
36. Craven, P A., C.M. Davidson, and F.R. DeRubertis. 1990. Increase in diacylglycerol mass in isolated glomeruh by glucose from de novo synthesis of glycerolipids. Diabetes. 39:667-674.
37. Wolf, B.A , J.R. Williamson, R.A. Easom, K. Chang, W.R. Sherman, and J Turk. 1991 Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest. 87:31-38.
38. Inoguchi, T., R. Battan, E. Handler, J.R. Sportsman, W. Heath and G.L. King. 1992. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad Sci. USA. 89.11059-11063.
39. de la Rubia, G., F.J. Oliver, T. Inoguchi, and G.L. King. 1992. Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes. Diabetes 41:1533-1539.
40. Williams, B., and R.W. Schrier. 1992. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes. 41:1464-1472.
41. Shiba, T., T. Inoguchi, J.R. Sportsman, W.F. Heath, S Bursell, and G.L. King. 1993. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol. 265:E783-E793.
42. Greene, D.A., and S.A. Lattimer. 1982. Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve Competitive inhibition by glucose and lack of an insulin effect. J. Clin. Invest 70:1009-1018.
43. Cammarata, P.R., H.Q. Chen, J. Yang, and T. Yorio. 1992. Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. II. Characterization of high- and low-affinity myo-inositol transport sites. Invest. Ophthalmol. & Visual Sci. 33:3572-3580
44. Del Monte, M.A., R Rabbani, T.C. Diaz, S.A. Lattimer, J. Nakamura, M.C. Brennan, and D A. Greene. 1991. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications. Diabetes. 40: 1335-1345.
45. Winegrad, A.I. 1987. Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes? Diabetes. 36:396-406.
46. Forstermann, U., J.S. Pollock, H.H. Schmidt, M Heller, and F. Murad. 1991. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci USA. 88.1788-1792.
47. Jun, C.D., H J. Hoon-Ryu, J.Y. Um, T.Y. Kim, J.M. Kim, S.S. Kang, H.M. Kim, and H.T. Chung. 1994. Involvement of protein kinase C in the inhibition of nitric oxide production from murine microglial cells by glucocorticoid. Biochem. Biophys. Res. Commun 199.633-638.
48. Kamata, K., N. Miyata, and Y. Kasuya. 1989. Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 97:614-618.
49. Cameron, N.E , and M.A. Cotter. 1992. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia. 35.1011-1019.
50. Ross, R.A., B.A. Spengler, and J.L. Biedler. 1983. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl Cancer Inst. 71:741-747.
51. Fisher, S.K., A.M. Heacock, and B.W. Agranoff. 1992. Inositol lipids and signal transduction in the nervous system: an update. J. Neurochem. 58:18-38.
52. Siefert, W., and P.S. Rudland. 1974. Cyclic nucleotides and growth control in cultured mouse cells: correlation of changes in intracellular 3′:5′ cGMP concentration with a specific phase of the cell cycle. Proc. Natl Acad. Sci. USA. 71:4920-4924.
53. Louis, J.C., M.O. Revel, and J. Zwiller. 1993. Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells. Biochem. Biophys. Acta 1177:299-306.
54. Thomas, T.P., R. Gopalakrishna, and W.B. Anderson 1987. Hormone-and tumor promoter-induced activation or membrane association of protein kinase C in intact cells. Methods Enzymol. 141:399-411.
55. Kraft, A.S., and W.B. Anderson 1983. Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane Nature (Lond.). 301:621-623
56. Lapetina, E.G., B. Reep, B.R. Ganong, and R.M. Bell. 1985. Exogenous sn-1,2-diacylglycerols containing saturated fatty acids function as bioregulators of protein kinase C in human platelets. J. Biol. Chem. 260:1358-1361.
57. Rodriguez-Pena, A., and E. Rozengurt. 1984. Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem Biophys. Res. Commun. 120.1053-1059.
58. Ballester, R., and O.M. Rosen 1985. Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12-myristate 13-acetate. J. Biol Chem 260:15194-15199.
59. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. 1989 Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun 159 548-553.
60. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Wash. DC). 258:607-614.
61. Greene, D.A., and S.A. Lattimer. 1986. Protein kinase C agonists acutely normalize decrease ouabain-inhibitable respiration in diabetic rabbit nerve Implications for (Na,K)-ATPase regulation and diabetic complications Diabetes. 35:242-245.
62. Nakane, M., J. Mitchell, U. Forstermann, and F. Murad 1991. Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys. Res. Commun. 180:1396-1402.
63. Bredt, D.S , C.D. Ferris, and S.H. Snyder. 1992. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase. protein kinase C, and calcium/calmodulin protein kinase, identification of flavin and calmodulin binding sites. J. Biol. Chem. 267:10976-10981.
64. Kawabe, J., Y. Ohsaki, and S. Onodera. 1992. Down-regulation of protein kinase C potentiates atrial natriuretic peptide-stimulated cGMP accumulation in vascular smooth-muscle cells Biochem. Biophys. Acta. 1175:81-87.
65. Hortelano, S., A M. Genaro, and L. Bosca. 1992. Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. Antagonism with the induction elicited by lipopolysaccharide. J. Biol. Chem. 267:24937-24940.
66. Severn, A., M.J. Wakelam, and F.Y. Liew 1992 The role of protein kinase C in the induction of nitric oxide synthesis by murine macrophages. Biochem Biophys Res Commun. 188:997-1002.
67. Hortelano, S , A.M Genaro, and L. Bosca. 1993. Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages. FEBS Lett. 320:135-139.
68. Bosca, L., and P.A. Lazo 1994. Induction of nitric oxide release by MRC OX-44 (anti-CD53) through a protein kinase C-dependent pathway in rat macrophages. J. Exp. Med. 179:1119-1126.
69. Davda, R.K., L.J. Chandler, and N.J. Guzman. 1994. Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase. Eur. J. Pharmacol. 266.237-244.
70. Murthy, K.S., J.G. Jin, and G.M. Makhlouf. 1994. Inhibition of nitric oxide synthase activity in dispersed gastric muscle cells by protein kinase C. Am. J Physiol 266:G161-G165.
71. Kim, J., H. Kyriazi, and D.A. Greene. 1991. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes 40:558-567.
72. Borghini, I., A. Ania-Lahuerta, R. Regazzi, G Ferrari, A Gjinovci, C.B Wollheim, and W.F. Pralong. 1994. Alpha, beta I, beta II, delta, and epsilon protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats J. Neurochem. 62:686-696.
73. Erne, P., N. Mazurek, C. Borner, J.F. Conscience, U. Eppenberger, and D. Fabbro. 1987. Translocation of protein kinase C is not required to inhibit the antigen-induced increase of cytosolic calcium in a mast cell line. Biochem. Biophys. Res. Commun. 143.252-259.
74. Diaz-Guerra, M.J., and L. Bosca. 1990. Lack of translocation of protein kinase C from the cytosol to the membranes in vasopressin-stimulated hepatocytes. Biochem J. 269:163-168
75. Henry, D.N., M Del Monte, D.A. Greene, and P.D. Killen 1993. Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. J Clin. Invest. 92:617-673.
76. King, G.L., S. Johnson, and G. Wu. 1990. Possible growth modulations involved in the pathogenesis of diabetic proliferative retinopathy. In Growth Factors in Health and Disease, B. Westermark, C. Betsholtz, and B. Hokfelt, editors. Excerpta Medica, New York. 303-317.
77. Akagi, Y., Y. Yajima, P.F. Kador, T. Kuwabara, and J.H. Kinoshita. 1984. Localization of aldose reductase in the human eye. Diabetes. 33:562-566.
78. Cammarata, P.R., and H.Q. Chen. 1994. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 1: A hypertonicity-induced protein enhances myo-inositol transport. Invest. Ophthalmol. & Visual Sci. 35:1223-1235.
79. Mistry, K.P., A. Beyer-Mears, and F.P. Diecke 1993. Mechanisms for D-glucose inhibition of myo-inositol influx into rat lens. Diabetes 42:1737-1744.
80. Lattimer, S.A., A.A. Sima, and D.A. Greene. 1989. In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists. Am. J. Physiol. 256:E264-E269.
81. Gupta, S , C. McArthur, C. Grady, and N.B. Ruderman. 1994. Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect. Am. J Physiol. 266:H2146-H2151.
82. Nakayama, I., Y. Kawahara, T Tsuda, M Okuda, and M. Yokoyama 1994. Angiotenssn II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J. Biol. Chem. 269:11628-11633.
83. Nguyen, B.L., M. Saitoh, and J A Ware. 1991. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am. J. Physiol. 261:H1043-H1052.
84. Greene, D.A., A.A. Sima, M J Stevens, E.L. Feldman, and S.A. Lattimer. 1992. Complications: neuropathy, pathogenetic considerations. Diabetes Care. 15:1902-1925.
85. Cameron, N.E., M.A. Cotter, and P.A. Low. 1991. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J. Physiol. 261:E1-E8.
86. Cameron, N.E., M.A Cotter, K. Ferguson, S. Robertson, and M.A. Radcliffe. 1991. Effects of chronic alpha adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats. Diabetes. 40:1652-1658.
87. Cameron, N.E., M.A. Cotter, and S. Robertson. 1992 Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia. 35:12-18.
88. Greene, D.A., A.A. Sima, M.J. Stevens, E.I., Feldman, P.D. Killen, D.N. Henry, T. Thomas, J. Dananberg, and S.A. Lattimer. 1993. Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage. Diabetes Metab. Rev 9:189-217.
89. Stevens, M.J., E.L. Feldman, and D A. Greene. 1995. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabetic Med. 12:566-579.
90. Cameron, N.E., M A. Cotter, K.C. Dines, E.K. Maxfield, F. Carey, and D.J. Mirrlees. 1994 Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism Diabetologia. 37 651-663.
91. Greene, D.A., P.V. DeJesus, and A.I. Winegrad. 1975. Effects of insulin and dietary myo-inositol on impaired motor nerve conduction velocity in acute streptozotocin diabetes. J. Clin. Invest. 55:1326-1336.
92. Gupta, S., I. Sussman, C.S. McArthur, K. Tornheim, R.A Cohen, and N.B. Ruderman. 1992. Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. J. Clin. Invest. 90:727-732.
93. Ghahary, A, S. Chakrabarti, A. A. Sima, and L.J Murphy. 1991. Effect of insulin and statil on aldose reductase expression in diabetic rats. Diabetes 40: 1391-1396.
94. Haefliger, I.O., A. Zschauer, and D.R. Anderson. 1994. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. Invest Ophthalmol. & Visual Sci. 35:991-997.
95. Clermont, A.C., M. Brittis, T. Shiba, T. McGovern, G.L. King, and S.E. Bursell. 1994. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps Invest. Ophthalmol & Visual Sci. 35:981-990.